Millennium Management’s Maravai LifeSciences MRVI Stock Holding History

Millennium Management’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$40.6M	Buy	6,508,220 +4,858,730	+295%	+$21M	0.01%	1030
2026 Q1	$4.67M	Sell	1,649,490 -147,562	-8%	-$500K	﹤0.01%	3021
2025 Q4	$5.84M	Buy	1,797,052 +1,357,349	+309%	+$4.57M	﹤0.01%	2840
2025 Q3	$1.26M	Buy	439,703 +191,616	+77%	+$489K	﹤0.01%	4440
2025 Q2	$598K	Sell	248,087 -1,128,634	-82%	-$2.37M	﹤0.01%	4780
2025 Q1	$3.04M	Sell	1,376,721 -530,540	-28%	-$2.1M	﹤0.01%	3377
2024 Q4	$10.4M	Sell	1,907,261 -2,418,051	-56%	-$15.6M	0.01%	2142
2024 Q3	$35.9M	Sell	4,325,312 -1,643,280	-28%	-$14.2M	0.02%	1058
2024 Q2	$42.7M	Buy	5,968,592 +713,639	+14%	+$6.16M	0.02%	907
2024 Q1	$45.6M	Sell	5,254,953 -531,896	-9%	-$3.6M	0.02%	883
2023 Q4	$37.9M	Buy	5,786,849 +1,524,650	+36%	+$9.85M	0.02%	998
2023 Q3	$42.6M	Buy	4,262,199 +4,040,786	+1,825%	+$44.4M	0.02%	814
2023 Q2	$2.75M	Buy	221,413 +211,020	+2,030%	+$2.85M	﹤0.01%	3201
2023 Q1	$146K	Sell	10,393 -2,585,155	-100%	-$37.1M	﹤0.01%	5290
2022 Q4	$37.1M	Buy	2,595,548 +799,274	+44%	+$12.6M	0.02%	959
2022 Q3	$45.9M	Buy	1,796,274 +1,687,021	+1,544%	+$42.3M	0.03%	727
2022 Q2	$3.1M	Sell	109,253 -555,426	-84%	-$17.6M	﹤0.01%	3263
2022 Q1	$23.4M	Buy	664,679 +143,060	+27%	+$4.8M	0.01%	1227
2021 Q4	$21.9M	Buy	521,619 +142,869	+38%	+$5.79M	0.01%	1353
2021 Q3	$18.6M	Buy	378,750 +100	+0%	+$4.88K	0.01%	1400
2021 Q2	$15.8M	Buy	378,650 +13,045	+4%	+$506K	0.01%	1430
2021 Q1	$13M	Sell	365,605 -340,093	-48%	-$11.3M	0.01%	1509
2020 Q4	$19.8M	Buy	+705,698	New	+$19.7M	0.01%	1080

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

1WCM

12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OAM

Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management's MRVI Position: Q2 2026 in Review

Millennium Management increased its Maravai LifeSciences (MRVI) stake by 295% in Q2 2026, buying an estimated $21M and bringing the position to 6,508,220 shares worth $40.6M. The position accounts for 0.01% of the portfolio, ranked #1030.

Millennium Management first reported a position in MRVI in Q4 2020 and has held it in 23 quarters since. The position peaked at $45.9M in Q3 2022. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

Millennium Management held 6,508,220 shares of Maravai LifeSciences worth $40.6M as of Q2 2026.
Millennium Management bought 4,858,730 Maravai LifeSciences shares in Q2 2026, an estimated $21M.
Maravai LifeSciences made up 0.01% of Millennium Management's portfolio in Q2 2026, its #1030 holding.
Millennium Management first reported a position in Maravai LifeSciences in Q4 2020 and has held it in 23 quarters since.
Millennium Management's Maravai LifeSciences position peaked at $45.9M in Q3 2022.
178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.